Literature DB >> 21224244

Don't 'agonise' over the mechanisms underlying beta-agonist-induced muscle hypertrophy!

P J Atherton1, N J Szewczyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21224244      PMCID： PMC3039251          DOI： 10.1113/jphysiol.2010.201459

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  4 in total

1.  Chronic treatment with the beta(2)-adrenoceptor agonist prodrug BRL-47672 impairs rat skeletal muscle function by inducing a comprehensive shift to a faster muscle phenotype.

Authors:  David J Baker; D Constantin-Teodosiu; Simon W Jones; James A Timmons; Paul L Greenhaff
Journal:  J Pharmacol Exp Ther       Date:  2006-07-14       Impact factor: 4.030

2.  Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.

Authors:  James G Ryall; Martin N Sillence; Gordon S Lynch
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

3.  Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice.

Authors:  René Koopman; Stefan M Gehrig; Bertrand Léger; Jennifer Trieu; Stéphane Walrand; Kate T Murphy; Gordon S Lynch
Journal:  J Physiol       Date:  2010-10-11       Impact factor: 5.182

4.  Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats.

Authors:  Isabelle Rieu; Hugues Magne; Isabelle Savary-Auzeloux; Julien Averous; Cécile Bos; M A Peyron; Lydie Combaret; Dominique Dardevet
Journal:  J Physiol       Date:  2009-09-14       Impact factor: 5.182
  4 in total
  1 in total

1.  Beta2 -adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men.

Authors:  Morten Hostrup; Søren Reitelseder; Søren Jessen; Anders Kalsen; Michael Nyberg; Jon Egelund; Michael Kreiberg; Caroline Maag Kristensen; Martin Thomassen; Henriette Pilegaard; Vibeke Backer; Glenn A Jacobson; Lars Holm; Jens Bangsbo
Journal:  J Physiol       Date:  2018-07-30       Impact factor: 5.182
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.